A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 97
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CSF
Long Form : coronary slow flow
No. Year Title Co-occurring Abbreviation
2021 A preliminary study of MMP-9 and sCD40L in patients with coronary slow flow. CRP, CSFP, cTFC, ELISAs, MMP-9, NCF, sCD40L
2021 Aortic flow propagation velocity and neutrophil-to-lymphocyte ratio in coronary slow flow. APV, NLR, TIMI
2021 Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia. ALB, CAE, LMR, LVEDD, LVEF, NLR, TIMI, URIC
2021 Eosinophil cationic protein: A new diagnostic biomarker in coronary slow flow phenomenon. ECP, TFC
2021 Evaluation of index of cardio-electrophysiological balance in patients with coronary slow flow. ECG, QTc, Tp-e, VA
2021 Incremental Value of Three-dimensional Speckle-tracking Echocardiography for Evaluating Left Ventricular Systolic Function in Patients with Coronary Slow Flow. AUC, IDI, LV, STE
2021 LncRNA NEAT1 Promote Inflammatory Responses in Coronary Slow Flow Through Regulating miR-148b-3p/ICAM-1 Axis. CCK-8, ceRNA, EdU, HUVECs, IL-6, lncRNAs, NEAT1, OGD, RIP, SAQ, sICAM-1, TNF-alpha
2021 Long Noncoding RNA AF131217.1 Regulated Coronary Slow Flow-Induced Inflammation Affecting Coronary Slow Flow via KLF4. hs-CRP, IL, KLF, lncRNAs, miR, TFC
2021 Slow Coronary Flow: Pathophysiology, Clinical Implications, and Therapeutic Management. ---
10  2021 The lncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p-MEF2A-ET-1 axis. CCK-8, ChIP, EdU, ELISA, ET-1, FMD, HUVECs, lncRNA, MEF2A
11  2021 The relationship between coronary slow-flow and frontal QRS-T angle. ECG, NCF
12  2020 An investigation of the relationship between arterial aortic stiffness and coronary slow flow that was detected during coronary angiography. ASIbeta, CSFP, PWV, ROC
13  2020 Analysis of two single-nucleotide polymorphisms (rs2241766 and rs1501299) of the adiponectin gene in patients with coronary artery disease and coronary slow flow. CAD, PCR, SNPs
14  2020 Association between impaired cutaneous microvascular endothelial function and lectin-like oxidized low-density lipoprotein receptor-1 in patients with coronary slow flow. LOX-1, sLOX-1, TFC
15  2020 Association of abnormal coronary sinus reflux with coronary slow flow and importance of the Thebesian valve. CMR, CS
16  2020 Atorvastatin improves the proliferation and migration of endothelial progenitor cells via the miR-221/VEGFA axis. EPCs, VEGFA
17  2020 Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome. MACEs, TTS
18  2020 Elevated Lipoprotein-Associated Phospholipase A2 is Valuable in Prediction of Coronary Slow Flow in Non-ST-Segment Elevation Myocardial Infarction Patients. CI, Lp-PLA2, NSTEMI, TIMI
19  2020 Establishing normal reference value of carotid ultrafast pulse wave velocity and evaluating changes on coronary slow flow. PWV, TIMI
20  2020 Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon. ADMA
21  2020 Evaluation of the Correlation between Serum Concentrations of Asymmetric Dimethylarginine and Corrected TIMI Frame Count in Patients with Slow Coronary Flow. ADMA, cTFC, LAD
22  2020 Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention. CI, CTO, FG, LDL, LDL-C, MACCE, MPV, NRP, OR, PCI
23  2020 Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow. Lp-PLA2, ROC, TFC, TIMI
24  2020 miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow. miRNAs, ROC
25  2020 Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow. CAD, CAD, ELISA
26  2020 Relationship Between Platelet to Lymphocyte Ratio and Stable Coronary Artery Disease: Meta-Analysis of Observational Studies. CAD, CCC, PLR
27  2020 The relationship between coronary slow flow phenomenon and carotid femoral pulse wave velocity and aortic elastic properties. cfPWV, TFC
28  2019 Anxiety and depression relationship with coronary slow flow. CAD, CAG
29  2019 Assessment of the relationship between coronary flow rates and myocardial perfusion abnormality in patients with nonobstructive coronary artery disease: an observational study in cardiac syndrome X and coronary slow flow. CSX, SDS, SPECT-MPI, TFC
30  2019 Correlation IMA with TIMI frame count in slow coronary flow: can it be a guide for treatment? IMA
31  2019 Early Assessment of Left Ventricular Function by Layer-Specific Strain and Its Relationship to Pulsatile Arterial Load in Patients with Coronary Slow Flow. ACI, GLS, LV, TFC
32  2019 Oxidant-Antioxidant balance in patients with coronary slow flow. Cp, LOOH, OSI, SH, TOS
33  2019 Prognosis of patients with previous myocardial infarction, coronary slow flow, and normal coronary angiogram. LVEF, MI
34  2019 Relationship Between the Reciprocal Change in Inflammation-Related Biomarkers (Fibrinogen-to-Albumin and hsCRP-to-Albumin Ratios) and the Presence and Severity of Coronary Slow Flow. CAD, hs-CRP
35  2019 Relationship of serum salusin beta levels with coronary slow flow. BMI, TFC
36  2019 Suspected Brugada Phenocopy Secondary to Coronary Slow Flow. BrP, BrS, SCD
37  2019 [Relationship between plasma miR-126 and coronary slow flow phenomenon]. RT-qPCR
38  2018 Alleviating Effect of Antidepressant Treatment on Psychiatric Symptoms and Cardiac Conditions in a Patient with Coronary Slow Flow Comorbid with Depression and Anxiety. CVD, TIMI
39  2018 Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow. CEPC, cTFC, hs-CRP, IL
40  2018 Circulating miRNA-155 as a Potential Biomarker for Coronary Slow Flow. hs-CRP, TFC
41  2018 Effect of Shexiang Tongxin Dropping Pills () on the Immediate Blood Flow of Patients with Coronary Slow Flow. CAG, TIMI
42  2018 Retinal fluorescein angiography: A sensitive and specific tool to predict coronary slow flow. ART, AVTT, OCAD, PI, RI
43  2018 Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study. BMI, hs-CRP, NSTEMI, TIMI
44  2018 The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine. CAD, IC, TFC
45  2017 Evaluation of ghrelin levels and endothelial functions in patients with coronary slow flowphenomenon. FMD, TIMI
46  2017 Evaluation of Plasma Thrombomodulin in Patients with Coronary Slow Flow. TFC, TIMI, TM
47  2017 Focusing on a complete blood cell parameter: mean platelet volume levels may be a predictor of coronary slow flow. CI, MPV, NCA
48  2017 Novel Ventricular Repolarization Indices in Patients with Coronary Slow Flow. ---
49  2017 Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients. ACS, HC, IL, LPS, miR-155, PBMC, SAP, TLR4, TNF
50  2017 Transcriptional activity of tumor necrosis factor-alpha gene in peripheral blood mononuclear cells in patients with coronary slow flow. PBMCs, qRT-PCR, TNF-alpha
51  2016 Decreased risk of ventricular arrhythmias with treatment of nebivolol in patients with coronary slow flow. QTd
52  2016 Elevated endocan concentration is associated with coronary slow flow. ELISA, TIMI
53  2016 Is dipyridamole useful in improving left ventricular systolic and diastolic function in patients with coronary slow flow? CDI, Em, IRT, LV, MPI, TDI
54  2016 Predictive Value of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Patients with Coronary Slow Flow. NLR, PLR, TFC
55  2016 The effect of trimetazidine on ventricular repolarization indexes and left ventricular diastolic function in patients with coronary slow flow. TMZ
56  2016 Vessel heterogeneity of TIMI frame count and its relation to P-wave dispersion in patients with coronary slow flow. CV, ECGs, PWD, TIMI
57  2015 Anxiety, Depression, and General Psychological Distress in Patients with Coronary Slow Flow. BAI, BDI, NCA, SCL-90-R, TIMI
58  2015 Assessment of the relationship between a narrow fragmented QRS complex and coronary slow flow. CAD, ECG, fQRS, TIMI
59  2015 Evaluation of Tp-Te Interval and Tp-Te/QT Ratio in Patients with Coronary Slow Flow Tp-Te/QT Ratio and Coronary Slow Flow. ---
60  2015 Left Ventricular Twist Mechanics Are Impaired in Patients with Coronary Slow Flow. GLS, LV, STE, TIMI, TPT, TPU
61  2015 Relationship between serum visfatin levels and coronary slow-flow phenomenon. TIMI
62  2014 Echo-tracking technology assessment of carotid artery stiffness in patients with coronary slow flow. AC, AIx, CAG, CCA, Ep, ET, hs-HSCRP, PWV
63  2014 Endothelial function and germ-line ACE I/D, eNOS and PAI-1 gene profiles in patients with coronary slow flow in the Canakkale population: multiple thrombophilic gene profiles in coronary slow flow. FMD, PCR, TIMI
64  2014 Intercellular adhesion molecule-1 K469E and angiotensinogen T207M polymorphisms in coronary slow flow. AGT, ICAM-1
65  2014 Mean platelet volume is not associated with coronary slow flow: a retrospective cohort study. MPV, TFC
66  2014 New markers for ventricular repolarization in coronary slow flow: Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio. ms, TIMI
67  2014 Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow. ET-1, LAD, LV, NO
68  2014 The association between coronary slow flow and platelet distribution width among patients with stable angina pectoris. Hb, NLR, PDW, RDW, TFC
69  2014 The association of serum albumin with coronary slow flow. hs-CRP, IL-6, s-albumin, TIMI
70  2014 The presence of fragmented QRS on 12-lead ECG in patients with coronary slow flow. fQRS
71  2014 The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study. ELISA, HDL, TIMI, UII
72  2013 A novel echocardiographic method as an indicator of endothelial dysfunction in patients with coronary slow flow. FMD, NCA
73  2013 Association between serum cystatin C levels and coronary slow flow. CAD, CysC
74  2013 Coronary slow flow and abnormal nocturnal blood pressure profile in normotensives. BP, CI, OR, TIMI
75  2013 Evaluation of circulation disorder in coronary slow flow by fundus fluorescein angiography. ---
76  2013 The relationship between serum bilirubin concentration and coronary slow flow. ---
77  2013 [Evaluation of myocardial perfusion in patients with coronary slow flow by myocardial contrast echocardiography]. ---
78  2013 [Reduced circulating endothelial progenitor cells is a risk factor of coronary slow flow]. EPCs
79  2012 A randomized, single-center double-blinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow flow phenomenon at 6-month follow-up. ---
80  2012 Effect of enhanced external counterpulsation on coronary slow flow and its relation with endothelial function and inflammation: a mid-term follow-up study. CFR, DPFV, EECP, FMD, hs-CRP, TTDE
81  2012 Evaluation of blood rheology in patients with coronary slow flow or non-obstructive coronary artery disease. NOCAD
82  2012 Reduced circulating endothelial progenitor cells in the coronary slow flow phenomenon. EPCs, TIMI
83  2011 Vascular endothelial function in patients with coronary slow flow and the effects of nebivolol. FMD, IVRT, LVEF, NO
84  2011 [The association of coronary slow flow with time to peak systolic strain]. TFC
85  2010 Aortic pressures, stiffness and left ventricular function in coronary slow flow phenomenon. LV
86  2010 The effects of perindopril on QT duration and dispersion in patients with coronary slow flow. DT, IVRT
87  2010 The relationship between coronary slow flow phenomenon and coronary calcium score. CAC, CSFP, HDL, TFC
88  2009 Regional functions of the left ventricle in patients with coronary slow flow and the effects of nebivolol. DT, LAD, LV
89  2009 The effects of nebivolol on P wave duration and dispersion in patients with coronary slow flow. DT, IVRT, PWD
90  2008 Carotid artery intima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow. CIMT
91  2008 Patients with coronary slow flow phenomenon demonstrate normal myocardial blood flow and arterial wave reflection between acute episodes. beta, MBF
92  2008 The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries. Cx, ET-1, LAD, TFC
93  2007 Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow. FMD, Hcy, MDA, SOD, TIMI
94  2006 Aortic pulse pressure and aortic pulsatility in patients with coronary slow flow. PP, TIMI
95  2006 P-wave duration and dispersion in patients with coronary slow flow and its relationship with Thrombolysis in Myocardial Infarction frame count. Pd, TIMI
96  2005 [Is slow coronary flow related with inflammation and procoagulant state?]. CRP, NCF, tPA, vWF
97  2004 The relationship between plasma endothelin-1, nitric oxide levels, and heart rate variability in patients with coronary slow flow. ET-1, HRV, NOx